Background-We explored the role that inhibitory heterotrimeric G-proteins play in ventricular arrhythmia. Methods and Results-Mice with global genetic deletion of G␣ i2 [G␣ i2 (Ϫ/Ϫ)] were studied and found, based on telemetry, to have a prolonged QT interval on surface ECG when awake. In vivo electrophysiology studies revealed that the G␣ i2 (Ϫ/Ϫ) mice have a reduced ventricular effective refractory period and a predisposition to ventricular tachycardia when challenged with programmed electrical stimulation. Neither control nor combined global deletion of G␣ i1 and G␣ i3 mice showed these abnormalities. There was no evidence for structural heart disease at this time point in the G␣ i2 (Ϫ/Ϫ) mice as assessed by cardiac histology and echocardiography. The absence of G␣ i2 thus leads to a primary electrical abnormality, and we explored the basis for this finding. With patch clamping, single isolated ventricular cells showed that G␣ i2 (Ϫ/Ϫ) mice had a prolonged ventricular action potential duration (APD) but steeper action potential shortening as the diastolic interval was reduced in restitution studies. Gene expression studies showed increased expression of L-type Ca 2ϩ channel subunits, and patch clamping revealed an increase in these currents in G␣ i2 (Ϫ/Ϫ) mice. There were no changes in K ϩ currents. Conclusions-The absence of inhibitory G-protein signaling mediated through G␣ i2 is a substrate for ventricular arrhythmias. (Circ Arrhythm Electrophysiol. 2010;3:391-400.)
S
udden cardiac death resulting from ventricular tachyarrhythmia represents a major healthcare issue. An estimated 300 000 cases per year are recorded in the United States, stressing the importance of accurate prediction and treatment of patients at particular risk. 1 Implantable cardiac defibrillators for the management of ventricular tachycardia have proven benefits; however, precise calculation of patients at greatest risk remains crude. 2 Pharmacological suppression of ventricular tachycardia also has been largely ineffective and, in some cases, proarrhythmic. 3 Thus, there is a pressing need to better understand the molecular pathways that determine the induction and persistence of ventricular tachycardia in an effort to develop treatment strategies.
Clinical Perspective on p 400
The action of the sympathetic and parasympathetic systems on the heart are opposing in nature. The sympathetic system acts through ␤-adrenoreceptors, and the stimulatory G-protein G s is positively inotropic, chronotropic, and lusitropic. In contrast, acetylcholine released from the vagus nerve through muscarinic receptors (largely M2) and inhibitory G-proteins is negatively chronotropic and inotropic. The ventricle expresses M2 muscarinic receptors at Ϸ300 fmol/mg of protein. 4 The density of innervation from the parasympathetic nervous system is less in the ventricle than in the supraventricular structures but is nonetheless present. At the cellular level, G i/o -proteins are involved in the inhibition of adenylyl cyclase, activation of phosphatidylinositol 3-kinase, and modulation of K ϩ and Ca 2ϩ channels. 5 The heterotrimer consists of a G␣ subunit that defines the particular family and a G␤␥ subunit. There are multiple isoforms of inhibitory G-proteins (G␣ i1 , G␣ i2 , G␣ i3 , and G␣ o with splice variants G␣ o1 and G␣ o2 ) and Ͼ1 member often is expressed in a single tissue. 5 In general, acetylcholine has no effect on basal L-type Ca 2ϩ currents in the ventricle, but it strongly antagonizes the increase on the application of a catecholamine or forskolin. 6 In contrast, the ␣ subunit of G s activates adenylyl cyclase 7 and may positively regulate the voltagegated calcium channel by direct action on the ␣ 1 subunit independent of protein kinase A. 8 There is also evidence for pathological changes in the cardiovascular system occurring with an imbalance of signaling through stimulatory and inhibitory heterotrimeric G-proteins. For example, in the failing heart, ␤1-adrenergic receptors are downregulated, and G␣ i/o expression, in particular G␣ i2 , is significantly increased. 9 Activation of the sympathetic nervous system, although acutely beneficial, is maladaptive in chronic heart failure. Chronic adrenergic receptor activation promotes cardiac myocyte apoptosis and ion channel remodeling and is proarrhythmic partly through cAMP-triggered activity. 10 This pathological process may be counteracted by signaling through cardiac G␣ i -coupled G-protein-coupled receptors within the heart. 11 Interestingly, whereas ␤1-adrenoreceptor receptor overexpression results in a dilated cardiomyopathy, ␤2 overexpression (which couples through both G␣ s and G␣ i/o mechanisms) has a much more modest phenotype, suggesting that G␣ i/o -coupled signaling may be cardioprotective. 10, 12 G␣ i2 also has been directly implicated in ventricular tachycardia induction from within pathological foci in the setting of right ventricular outflow tract tachycardia. A somatic cell mutation (F200L) from within the arrhythmia focus results in loss of function of G␣ i2 , resulting in failed suppression of forskolin-stimulated cAMP production. 13 It is known that increases in sympathetic drive can initiate ventricular tachyarrhythmias and that vagal nerve activation in an opposing fashion can terminate ventricular tachycardia and increase the ventricular fibrillation threshold. 14 -16 Furthermore, lethal arrhythmias often can be precipitated by exercise and stress because of the activation of ␤-adrenergic pathways in defined arrhythmic syndromes, and this is particularly the case in some variants of the long QT syndrome. 17 In this study, we address the question of whether signaling through inhibitory heterotrimeric G-proteins is pro-or antiarrhythmic. We show that the genetic deletion of G␣ i2 in mice leads to a proarrhythmic substrate partly accounted for by increased L-type Ca 2ϩ channel activity.
Methods

Experimental Animals
Mice with global deletion of G␣ i2 [G␣ i2 (Ϫ/Ϫ)] and the combined global deletion of G␣ i1 and G␣ i3 were generated by homologous recombination on a 129SvEv background. The gene-targeting strategy and confirmation of selective G␣ i2 deletion have been published previously. 18 
Gene Expression
The methods for the gene expression arrays and quantitative real-time polymerase chain reaction are provided in the online supplement.
Telemetry Implantation
Details of telemetry system implantation have been described previously. 20 Recording leads were tunneled subcutaneously in a conventional lead II ECG configuration to continuously record surface ECG after a 2-week period of surgical recovery. Single-lead telemetry data were recorded continuously over 48 hours to look for evidence of spontaneous arrhythmia. To record standard surface ECG parameters, consecutive individual ECG complexes recorded over 2 minutes during sinus rhythm at high sampling frequency (2000 Hz) were analyzed (Ͼ1000 ECG complexes/mouse) using an ECG analysis extension module of CHART 4.0 software.
Histology and Isolation of Cardiomyocytes
The protocols for the histological study of the heart and the isolation of single cardiomyocytes are provided in the online supplement.
Single-Cell Electrophysiology
Patch-clamp current recordings were performed with an Axopatch 200B amplifier using fire-polished pipettes with a resistance of 3 to 4 mol/L⍀ pulled from filamented borosilicated glass capillaries (Harvard Apparatus, 1.5 mm ODϫ1.17 mm ID). Data were acquired and analyzed with a Digidata 1322A interface and pCLAMP software version 10. All experiments were done at room temperature. Drugs were applied by a gravity-driven system. Further details are provided in the online supplement.
In Vivo Electrophysiological and Programmed Ventricular Stimulation Protocols
Mice were anesthetized with continuous 2.0% isoflurane gas. After needle electrodes were inserted to record surface ECG, an octapolar 1.1F ultraminature cardiac electrophysiology instrument was inserted into the right ventricular apex through the right internal jugular vein to pace the heart. Cardiac pacing using extrastimulation protocols was performed with an S88-Grass stimulator to record in vivo cardiac electrophysiological parameters. These protocols included sinus node recovery time, arterioventricular (AV) nodal effective refractory period, and 2:1 AV block-coupling interval from atrial pacing and ventricular effective refractory period (VERP 600 ). Finally, a ventricular stimulation protocol was performed whereby successive extrastimuli (up to 4 [S 2 -S 3 -S 4 -S 5 ]) were added to the basic drive train (15 paced beats at 100-milliseconds [ms] coupling interval) to provoke ventricular arrhythmia. If unsuccessful, 0.1 mg/kg IP isoprotenerol was administered, and the procedure was repeated. Ventricular tachycardia (VT) was defined as at least 4 beats of pacing-induced broad complex tachycardia that was qualitatively different from sinus rhythm. (Atrial electrograms confirmed AV dissociation during tachycardia). VT Ͼ10 cycle lengths was defined as sustained VT (ie, a positive study). These definitions of VT are identical to those recently published. 21
Echocardiography
Mice were placed in the supine position, and transthoracic echocardiography was performed under 1.0% isoflurane anesthesia using a commercial echocardiography machine with a 14-MHz probe recording at a depth of 0 to 1 cm. End-diastolic and end-systolic dimensions were determined from a parasternal short-axis view by M-mode at the papillary muscle level. Measurements were taken of the internal dimension of the cavity using the leading edge-to-leading edge convention. Aortic blood flow velocities were determined by pulsed-wave Doppler in the aortic arch before the bifurcation of the right carotid artery. The direction of blood flow was confirmed by color Doppler. Stroke volume was determined as the product of the velocity time integral and the vessel cross-sectional area [ϫ(0.5ϫdiameter) 2 ]. Prior studies in mice of this age showed the aortic diameter to be 1.34 mm; thus, a cross-sectional area of 0.67 2 ϫ was assumed for all animals studied. The peak aortic blood flow velocity was measured as the average maximum velocity from 6 velocity-time traces. Heart rate was determined by measuring the time between 6 consecutive cycles from the start of each Doppler trace. Cardiac output was calculated as the product of heart rate and stroke volume.
Statistical Analysis
Continuous data are presented as meanϮSEM and categorical data as percentages. The following statistical tests were used: Student t test to compare 2 groups; 1-way ANOVA with a Bonferroni post hoc test to compare 3 groups; and 2-way ANOVA to compare the data in Figures 1B, 1C , and 2D. Fisher exact test of proportions was used to compare the induction of VT between G␣ i2 (Ϫ/Ϫ) and control. Standard linear regression was used, and a correlation coefficient and slope are shown for the data in Figure 1 . The slopes were compared with a method equivalent to the analysis of covariance. A PϽ0.05 was taken to be statistically significant. All statistical analyses were performed with GraphPad Prism version 4.0.
Results
G␣ i2 (؊/؊) Mice Have Spontaneous Ventricular Ectopy and QT Interval Prolongation
We have recently reported that G␣ i2 (Ϫ/Ϫ) mice have impaired heart rate variability and lose the negative chronotropic response to carbachol 20 probably because G␣ i2 acts as the key molecular link between the M2 muscarinic receptor and the G-protein-gated K ϩ channel in sinoatrial nodal cells. In the course of these telemetry studies in conscious and ambulatory G␣ i2 (Ϫ/Ϫ) mice, we noted that 2 of the 6 mice studied, under basal conditions exhibited significant spontaneous ventricular ectopic activity and aberrantly conducted beats ( Figure 3A ). This finding prompted us to closely examine the surface ECG parameters in all these mice. We noted that the G␣ i2 (Ϫ/Ϫ) mice unexpectedly had QT interval prolongation despite relative tachycardia ( Figure 3B ), and this was reflected in a prolonged QT c 20 (Table 1) . These abnormalities (and spontaneous ectopy) were not seen in control mice or a separate group of mice with the combined global genetic deletion of G␣ i1 and G␣ i3 (Table 1) .
G␣ i2 (؊/؊) Mice Have a Proarrhythmic Substrate
We observed occasional unexpected death in several G␣ i2 (Ϫ/Ϫ) mice, although we were not able to record terminal arrhythmia, and this has been observed previously. 22 To investigate further this potential substrate, we used in vivo electrophysiological studies in anesthetized mice. The results of these studies are shown in Table 2 . In particular, we noted that the minimum ventricular S1-S2 coupling interval capable of ventricular capture (VERP) was significantly shorter in G␣ i2 (Ϫ/Ϫ) mice compared with control mice ( Figure 4A and Table 2 ). A reduction in VERP is proarrhythmic in situations of both reentry and triggered activity. These abnormalities were not seen in control mice or in mice with the combined global genetic deletion of G␣ i1 and G␣ i3 (supplemental table II). G␣ i2 (Ϫ/Ϫ) mice had an increased incidence and duration of induced ventricular tachycardia ( Figure 4B ). We were able to induce sustained VT in 7 out of 11 (63.6%) G␣ i2 (Ϫ/Ϫ) mice compared with 2 out of 12 (16.7%) littermate controls ( Figure 4C , Pϭ0.023, Fisher exact test). Additionally, a significant increase in mean VT duration was seen in G␣ i2 (Ϫ/Ϫ) mice compared with control mice ( Figure 4D ).
A Primary Electrical Abnormality Exists in G␣ i2 (؊/؊) Mice
One possible explanation is that mice studied at this age (12 to 14 weeks) have developed pathological heart disease, and the arrhythmic phenotype is secondary to this. However, there was no evidence of functional impairment in contractile function or other abnormalities as assessed using echocardi- ography in G␣ i2 (Ϫ/Ϫ) mice compared to control wild-type mice ( Figure 5 and supplemental table I) . Furthermore, when we harvested the organs, there was no evidence of gross hypertrophy when comparing the ratio of heart weight (mg) to body weight (g) or to tibial length (mm). In control mice (nϭ4), the ratio of heart weight to body weight was 5.02Ϯ0.20 mg/g, and in G␣ i2 (Ϫ/Ϫ) mice (nϭ4), 5.34Ϯ0.07 mg/g (Pϭ0.18). In control mice, the ratio of heart weight to tibial length was 5.37Ϯ0.34 mg/mm, and in G␣ i2 (Ϫ/Ϫ) mice, 5.20Ϯ0.23 mg/mm (Pϭ0.69). Finally, at cardiac histological examination, ventricular dimensions were normal (supplemental figure IA), myocytes were not hypertrophied, and no evidence of fibrosis existed in G␣ i2 (Ϫ/Ϫ) mice (supplemental figure IB) .
The APD and Its Rate Dependence
The correlation of ventricular action potential depolarization and repolarization with the QRS-T complex on the ECG is not as well established in mice as in larger mammals. 23 Thus, we isolated single cardiac ventricular myocytes and studied the action potential characteristics using patch clamping. We found that the later phases of repolarization were significantly prolonged in G␣ i2 (Ϫ/Ϫ) mice compared to control as reflected in a significantly prolonged 50% and 90% repolarization time ( Figure 1A and Table 3 ). There was no difference in magnitude of the initial depolarization or the resting membrane potential between the 2 groups (Table 3) .
We next examined the rate dependence by constructing single-cell restitution curves (see Methods section and Figure  1B ). There were significant differences between the G␣ i2 (Ϫ/Ϫ) mice and control mice under basal conditions and in the presence of isoprenaline (both PϽ0.01, 2-way ANOVA) ( Figure 1B and 1C) . Specifically, the slope of the restitution curve in its linear phase was steeper in the G␣ i2 (Ϫ/Ϫ) mice compared to the control mice ( Figure 1E) Table 3 ). D, In Ba 2ϩ -containing solutions, a similar increase was observed in basal and isoprenaline-induced currents. E, Representative recordings of outward K ϩ currents in control and G␣ i2 (Ϫ/Ϫ) mice are shown. The mean current parameters are summarized in Table 3 , but there were no significant differences between the 2 groups. NS indicates not significant. *PϽ0.05.
Increased L-Type Ca 2؉ Currents Contribute to the Abnormality
The observed abnormalities in repolarization could be accounted for by increases in inward current in particular through L-type Ca 2ϩ channels or a decrease in outward K ϩ currents. These abnormalities could arise through changes in gene expression and, concomitantly, protein levels or, alternatively, changes in the surface expression or activity of these channels. Thus, we initially ran gene expression arrays and compared G␣ i2 (Ϫ/Ϫ) mice with controls. There is evidence for remodeling of the electrophysiological properties of cardiac myocytes in a number of pathological states. In particular, there have been reports of a decreased expression of K ϩ channels resulting in a prolonged APD. 24 However, at the mRNA level, gene-array studies comparing control and G␣ i2 (Ϫ/Ϫ) mice showed little change in the relevant K ϩ channel genes, and in some cases, their expression was even increased (Table 4 ). In contrast, we did find a significant increase in expression (Ϸ2-fold) in G␣ i2 (Ϫ/Ϫ) mice of the calcium channel alpha subunit CACNA1C (Ca v 1.2), which underlies the L-type calcium current, and SCN5A, which underlies the rapidly inactivating sodium current in ventricular myocytes (Table 4) . We sought to confirm the changes in gene expression using quantitative real-time polymerase chain reaction (Figure 2A ). The only ion channel gene with significant increased expression (⌬⌬Ct Ͼ1 corresponding to a 2-fold change) was CACNA1C (Ca v 1.2).
Thus, we measured calcium currents in single ventricular myocytes using patch clamping. Representative recordings and current-voltage relationships are shown in Figure 2B . There was a significant increase in L-type calcium currents measured under basal conditions when using Ca 2ϩ as the charge carrier ( Figure 2C and Table 3 ). A similar increase was present using Ba 2ϩ as the charge carrier under basal conditions, and with application of isoprenaline, in myocytes isolated from the G␣ i2 (Ϫ/Ϫ) mice compared to control mice ( Figure 2D ). In a 2-way ANOVA, if the rows are with and without isoprenaline and the columns are the genotype, then the row factor has a Pϭ0.0009 and the column factor, Pϭ0.02. The interaction factor is not significant (Pϭ0.49) . Nifedipine blocked the current in cells where it was tested.
We also measured outward K ϩ currents (see Methods section), and these were not significantly changed in the G␣ i2 (Ϫ/Ϫ) mice compared to control mice ( Figure 2E and Table  3 ). There were no differences in cell capacitance between the 2 groups of mice (Table 3) .
Discussion
Our findings show that the absence of the inhibitory G-protein G␣ i2 (but not G␣ i1 and G␣ i3 ) leads to a proarrhythmic substrate in the ventricle, resulting in a long QT c interval and a predisposition to ventricular tachycardia. This is reflected at the cellular level, with a prolonged ventricular action potential most likely resulting from changes in expression and regulation of L-type Ca 2ϩ currents. Additionally, we and others have observed unexpected sudden death in G␣ i2 (Ϫ/Ϫ) mice, but we did not study this prospectively. 22 Furthermore, during short-term telemetry, we did not observe a lethal ventricular arrhythmia, although we did observe qualitatively an increased ventricular ectopic burden that we never saw in the controls. However, during minimally invasive electrophysiology testing, G␣ i2 (Ϫ/Ϫ) mice had a shortened VERP, a known proarrhythmic substrate. Additionally, we were able to induce VT significantly more easily in G␣ i2 (Ϫ/Ϫ) mice than controls, but not every G␣ i2 (Ϫ/Ϫ) mouse developed VT, and it is worth noting that the 129Sv strain is relatively resistant to ventricular arrhythmia. 25 Fur- thermore, in a proportion of the G␣ i2 (Ϫ/Ϫ) mice, cAMP responses are relatively well preserved. 26, 27 We performed studies to investigate potential mechanisms for the long QT interval on the ECG and the prolonged APD in single-cell patch clamping. The latter is hypothesized to provide important observations because these measurements were made in the absence of extracellular signaling and agonists for these pathways, contrasting the in vivo situation where tonic regulation of ion channel currents via signaling pathways also will make an important net contribution to cardiac cell excitability. It is worth emphasizing that the in vivo phenotype of the G␣ i2 (Ϫ/Ϫ) mice also will be significantly influenced by changes in L-type calcium channel regulation. The absence of muscarinic receptor regulation of this current in G␣ i2 (Ϫ/Ϫ) mice already has been established, and potentially in vivo, this will considerably exacerbate the increase in the calcium current as the heart is continuously exposed to varying vagal and sympathetic drives. 28 The loss of the muscarinic regulation of CACNA1C (Ca v 1.2) will ensure that Ca 2ϩ currents are larger for any given level of sympathetic-to-vagal balance. Our data suggest, however, that the change in APD is due to a long-term change in channel density at the membrane due to changes in expression or trafficking. Our studies revealed an increase in calcium channel expression and currents in the G␣ i2 knockout mice. Previous studies have shown no significant change, although there was a trend toward this in the data, and the experimental conditions were different. 28 That defects in L-type calcium channels might be associated with a long QT c interval is very much an emerging theme. Timothy syndrome is characterized by mutations in CACNA1C and prolonged QT c interval, predisposition to sudden death, autism, and a variety of defects in other tissues. 29 Ras associated with diabetes, a Ras-related guanosine triphophatase, is important in governing Ca v 1.2 channel trafficking. Overexpression of a dominant negative construct in mice and guinea pigs led to a doubling of L-type calcium current (a magnitude of change comparable to ours) Electrophysiological parameters recorded in single-cell studies from ventricular myocytes of control and G␣ i2 (Ϫ/Ϫ) mice. D indicates depolarization during action potential; APD50, 50% repolarization time; APD90, 90% repolarization time; Em, resting membrane potential; Ica, calcium current with calcium as a carrier; IK peak, IK plateau, potassium current measured with 4.5-second pulse at the peak and plateau phases; IK 1, IK 2, fast and slow inactivation constants of the K ϩ currents; Ica, tau of deactivation of Ica; WT, wild type.
and severe prolongation of the QT c interval together with an arrhythmogenic phenotype. 30 Finally, recent large-scale human genetic studies have shown linkage of variations in the population QT c interval to variants within the NOS1AP gene that encodes an adaptor protein for nitric-oxide synthase 1. 31 Subsequent electrophysiological studies have revealed that the protein can regulate the expression of calcium currents in cardiac myocytes. 32 The exact link between inhibitory G-protein signaling and ion channel gene expression is unclear, and we are actively investigating this. For example, it is known that the promoter for the ␣1C calcium channel contains a cAMP response element, 33 and this pathway involving activation of cAMP response element-binding protein is an obvious candidate.
We also examined the rate dependence of APD and found that as the test interval decreased, the action potential shortened more steeply in the G␣ i2 ([minus/Ϫ) mice than in controls. This is inherently proarrhythmic as it may lead to repolarization alternans, a known marker for ventricular arrhythmia. 34 It also may help to rationalize how a shortened VERP and prolonged QT interval can both be present. Thus, at normal heart rates, the APD (and QT c interval) are relatively prolonged in the G␣ i2 ([minus/Ϫ) mice. However, at higher rates, the slope of the restitution curve in the linear phase is steeper in these mice, and thus, APD shortens more, resulting ultimately in a reduced VERP. The decrease in VERP would support reentrant circuits by shortening the potential path length. We have not seen evidence for early or delayed afterdepolarizations in these experiments and thus believe that there is not a prominent substrate for triggered activity. Both of these can occur because of abnormalities in Ca 2ϩ handling. 35 For example, administration of an L-type Ca 2ϩ channel agonist can lead to early afterdepolarizations. 36 However, myocardial contractility as measured using echocardiography in our study was not different. Furthermore, other investigators have examined Ca 2ϩ transients and contractility in G␣ i2 (Ϫ/Ϫ) mice and found no differences under control conditions or after the addition of isoprenaline. 37 We saw no evidence for structural heart disease in these mice, but we only examined this at a relatively young age, and it is not clear what happens as the mice age.
There are debates about what can be learned from murine models, 38 but what are the potential pathophysiological implications of our observations? There has been a substantial focus on the role of aberrant signaling in heart failure through ␤-adrenergic receptors, particularly in light of the beneficial outcomes of ␤-blockers on survival. 11, 39 It has been established that there is an enhanced expression of G␣ i2 in heart failure. 9 Our results would suggest that increased expression may be a potential protective mechanism against malignant ventricular tachyarrhythmias. More broadly, parasympathethic modulation of cardiac rhythm is considered protective against ventricular arrhythmia. 40 In contrast, parasympathetic attenuation manifesting as a reduced heart rate variability signal is a powerful predictor of sudden cardiac death in heart failure 41 and a number of other cardiac pathologies. 42 Interestingly, pravastatin treatment has been reported to selectively upregulate G␣ i2 expression and increase highfrequency power. 43 We have previously described increased heart rate and selective loss of high-frequency power in mice deficient for G␣ i2 (but not G␣ i1 , G␣ i3 , or G␣ o ). 20 In the setting of hypertrophic cardiomyopathy, an increased of expression of G␣ i1 has been proposed to be proarrhythmic. 44 Our studies failed to reveal any significant abnormalities in mice with combined global genetic deletion of G␣ i1 and G␣ i3 . Intriguingly, such remodeling may only become important in certain disease settings, and different inhibitory G-protein isoforms may exhibit differential effects under these conditions. 
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